PIEZO1 and colonic neoplasm: Consistent with the in-situ results, Piezo1 was overexpressed in the CD133+CD44+ fraction of multiple colon cancer cell lines, including HCT-116, HCT-8, SW480 and HT-29 (Fig. 1D; Supplementary Figure 1).